|
India Leads Asian Biotech Sector
Clive James, Chairman, International Service for the Acquisition of
Agri-biotech Applications (ISAAA), said in a statement as reported on
February 20, 2007 by checkbiotech.org that India is fast evolving as a
leading biotech region in Asia, outshining China for the first time in
terms of total hectare land planted with biotechnology seeds.
advertisement
In 2006, Indias area planted with biotech cotton grew triple-fold (Indias
first commercialized biotech crop) from the last year. The total biotech
hectare in India now stands at an impressive 3.8 million as against 3.5
million in China.
Quality seeds with good biotechnology are making the rise in
productivity of Indian cultivators stronger.
After biotech cotton, the next major crop to be traded in the Asian
market will be golden rice. This variety of rice is fortified with
Vitamin A - essential for vision, and the intestinal, urinary, and
respiratory tracts.
The biotech development is immensely important for agriculture as a
whole as researchers search for ways to make a variety of crops better.
Biotechnology is an important tool being rapidly adapted and used by
farmers in developing countries and is greatly influencing the countries
development and thereby, their economy.
Asian cultivators have adopted GM (genetically modified) crops that
are insect-resistant, pest-resistant, and have many other additional
benefits. Countries like India are making huge investments in the
research of agricultural biotechnology to meet their surging needs for
food, fuel, and fiber.
India is expected to develop a national chain of research
laboratories by infusing $80 Million in 2007.
According to the RNCOS report Indian Biotechnology Market Outlook
(2006), biotech will greatly influence the Indian agriculture sector by
developing a large number of GM seeds. Amplifying at the rate of 28.09%
from 2005, the Indian biotech industry is believed to reach the level of
US$ 5 Billion by 2010 end.
The market research report also discusses the position of Indian
biotech sector with respect to Asia-Pacific region, and its market
performance. The report gives a detailed account of agri biotech in the
country supported by statistical data. It provides an insight into the
market size, domestic and exports market, and market segmentation
covering vaccines, biogenerics, therapeutics, etc. Investment scenario,
employment opportunities, government initiatives and regulatory
environment have been given in detail for investors.
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm.
It has a team of industry experts who analyze data collected from
credible sources. They provide industry insights and analysis that helps
corporations to take timely and accurate business decision in today's
globally competitive environment.
For more information visit:
http://www.rncos.com/Report/Biotech14.htmm
Current Industry News:
http://www.rncos.com/blog
Would you like to see your news and articles here? GO>>
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com®, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com® endorsing the content as a recommendation to buy or sell stock.
|
